A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The Transform trial, a collaborative effort funded by Prostate Cancer UK and the ...
Landmark UK prostate cancer screening trial begins with first men tested - Trial will inform future population-wide prostate cancer screening programmes for men ...
As the saying goes, you are what you eat, and that is true with your health as well. Health issues can be directly affected by the food you consume. These particular fast food menu items are linked to ...
FDA fast track enables increased FDA-company interactions and potential rolling BLA submission to accelerate development for serious diseases with unmet need. AKY-1189 uses a miniprotein ...
Triplet therapy with ADT, darolutamide, and biweekly docetaxel for high-risk metastatic castration-sensitive prostate cancer (TRIC): An open-label, single-arm phase II clinical trial. This is an ASCO ...
Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...
Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results